Ibrance 125 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26FXT2Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,110
Award facts
- Contract value 100% obligated
- $17,110.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $17,110.44 delivery order to Amerisourcebergen Drug Corp on April 14, 2026, for Ibrance 125 mg tablets.
Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of May 5, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FXT2Q?
SPE2DR26FXT2Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 14, 2026.
How much is contract SPE2DR26FXT2Q worth?
The government has obligated $17,110 on SPE2DR26FXT2Q.
Is contract SPE2DR26FXT2Q an order under another contract?
Yes. SPE2DR26FXT2Q is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXT2Q competed?
The extent of competition for SPE2DR26FXT2Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award